Eyetech Jumps on Merger News

Panacos Pharmaceuticals gives results of a clinical study of its HIV drug, and more of Monday's stocks in the news

OSI Pharmaceuticals (OSIP ) agrees to acquire Eyetech Pharmaceuticals (EYET ) for about $935 million in cash and stock, or $20 per share.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.